Key facts
- What it measures: the concentration of a pancreatic digestive enzyme in stool.
- Sample matters: watery stool can dilute the result.
- Low is a clue: interpretation needs symptoms, history and an appropriate sample.
- Normal has limits: it does not completely exclude pancreatic enzyme insufficiency.
Pancreatic elastase-1, also called fecal elastase or stool elastase, is an enzyme made by the pancreas. Measuring it in stool helps assess whether enough pancreatic digestive enzymes reach the intestine. A shortage is called exocrine pancreatic insufficiency (EPI) and can affect nutrient absorption. This test is more useful for detecting severe EPI than mild disease. [1]
How to read pancreatic elastase results
Results are usually reported in micrograms per gram of stool (µg/g). Read your laboratory’s reference interval alongside these clinical interpretation limits. The American Gastroenterological Association recommends testing a solid or semisolid sample. [2]
- Below 100 µg/g: provides substantial evidence for EPI in an appropriate sample; a clinician still needs to assess the context and cause.
- 100–200 µg/g: an indeterminate result. It does not, by itself, confirm mild EPI.
- Above 200 µg/g: commonly within the normal reference interval. A normal result does not fully rule out EPI, particularly milder disease. [3]
Why watery stool can give a low result
Elastase is measured as a concentration. Extra water in a loose sample can dilute it and produce a low reading that does not accurately reflect pancreatic function. Ask your clinician or the laboratory whether a repeat on a formed sample is appropriate. Follow the kit’s collection instructions; do not assume every low result is either EPI or a sampling error. [4]
Two examples: A result of 150 µg/g from a formed sample is indeterminate and needs clinical interpretation. A result of 80 µg/g from watery stool raises both the possibility of EPI and a sample-dilution concern. Neither example tells you the underlying cause.
What to discuss with your clinician
Bring the full report and note your stool consistency at collection, ongoing symptoms and any weight changes. Depending on the findings, evaluation may include medical history, an examination, nutritional blood tests or additional testing. Persistent greasy stools, diarrhea or unintended weight loss deserve medical assessment even when elastase falls within the reference interval. [5]
The GI-MAP places elastase alongside other markers, including steatocrit, a stool-fat measurement. They describe different aspects of digestion; one cannot substitute for the other or explain every digestive symptom. See the sample report for how results are presented. [4]
Frequently asked questions
Is elastase-1 on the standard GI-MAP?
Yes. Pancreatic elastase-1 is included among the digestion and intestinal-health markers on the standard GI-MAP panel. It is measured by immunoassay, not the qPCR method used for microbial targets. [4]
Is a pancreatic elastase result of 800 high?
A result of 800 µg/g is above the usual low-elastase cutoffs. Check the reference interval on your own report. This number alone does not establish that every aspect of pancreatic health is normal. [3]
Is low pancreatic elastase serious?
A low result deserves medical follow-up, especially with persistent greasy stools or unintended weight loss. Its meaning depends on the concentration, stool consistency, symptoms and medical history. It does not identify the underlying cause by itself. [1] [5]
Have a result? Review it with your clinician. Exploring testing? Start with what the panel includes.
Explore GI-MAP markers → See test costSources
- MedlinePlus, U.S. National Library of Medicine. Stool elastase test.
- American Gastroenterological Association. Clinical practice update: EPI evaluation and interpretation (2023).
- Mayo Clinic Laboratories. Pancreatic elastase, feces: reference values and cautions.
- Diagnostic Solutions Laboratory. GI-MAP white paper (2025), digestion markers, pages 32–33. Laboratory methods and sample limitations; clinical thresholds above follow AGA guidance.
- National Institute of Diabetes and Digestive and Kidney Diseases. Diagnosis of exocrine pancreatic insufficiency.